Aldehyde dehydrogenase as an alternative to enumeration of total and viable CD34⁺ cells in autologous hematopoietic progenitor cell transplantation

References

• Randall TD, Weissman IL. Characterization of a population of cells in the bone marrow that phenotypically mimics hematopoietic stem cells: resting stem cells or mystery population? Stem Cells. 1998;16:38–48.
   Google Scholar
• Osawa M, Hanada, K, Hamada H, Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34- low/negative hematopoietic stem cell. Science. 1996;273: 242–5.
   PubMed Web of Science ®Google Scholar
• Goodell MA, Rosenzweig M, Kim H, Marks DF, De-Maria M, Paradis G, . Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med. 1997;3:1337–45.
   PubMed Web of Science ®Google Scholar
• Bhatia M, Bonnet D, Murdoch B, Gan OI, Dick JE. A newly discovered class of human hematopoietic cells with SCID-repopulating activity. Nat Med. 1998;4:1038–45.
   PubMed Web of Science ®Google Scholar
• Jones RJ, Collector MI, Barber JP, Vala MS, Fackler MJ, May WS, . Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity. Blood. 1996;88:487–91.
   PubMed Web of Science ®Google Scholar
• Gentry T, Foster S, Winstead L, Deibert E, Fiordalisi M, Balber A. Simultaneous isolation of human BM hematopoietic, endothelial and mesenchymal progenitor cells by flow sorting based on aldehyde dehydrogenase activity: implications for cell therapy Cytotherapy. 2007;9:259–74.
   Google Scholar
• Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34+ cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
   PubMedGoogle Scholar
• Sieff CA, Mulligan RC, Johnson RP. Identification of Viable and Progenitor cells with Aldefluor. Stemcell Technologies Technical Bulletin. www.stemcell.com: accessed 10 May 2011.
   Google Scholar
• Draper NR, Smith H. Applied Regression Analysis. 3rd. New York: Wiley; 1998.
   Google Scholar
• Gunduz E, Demirel G, Bal C, Gulbas Z. Evaluation of mobilized peripheral stem cells according to CD34 and aldehyde dehydrogenase expression and effect of SSClo ALDHbr cells on hematopoietic recovery. Cytotherapy. 2010;12:1006–12.
   PubMed Web of Science ®Google Scholar
• Lioznov M, Dellbrügger C, Sputtek A, Fehse B, Kroger N, Zander AR. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM. Bone Marrow Transplant. 2008;42:121–8.
   PubMed Web of Science ®Google Scholar
• Cai J, Weiss ML, Rao MS. In search of stemness. Exp Hematol. 2004;32:585–98.
   PubMed Web of Science ®Google Scholar
• Jones R, Barber J, Vala M, Collector MI, Kaufmann SH, Ludeman SM, . Assessment of aldehyde dehydrogenase in viable cells. Blood. 1995;85:2742–6.
   PubMed Web of Science ®Google Scholar
• Storms RW, Green PD, Saford KM, Niedzwiecki D, Cogle CR, Colvin OM, . Distinct hematopoietic progenitor compartments are delineated by the expression of aldehyde dehydrogenase and CD34. Blood. 2005;106:95–102.
   PubMed Web of Science ®Google Scholar
• Fallon P, Gentry T, Balber AE, Boulware D, Janssen W, Smilee R, . Mobilized peripheral blood SSClo ALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation. Br J Haematol. 2003;122:99–108.
   PubMed Web of Science ®Google Scholar
• Lioznov MV, Freiberger P, Kröger N, Zander AR, Fehse B. Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant. 2005;35:909–14.
   PubMed Web of Science ®Google Scholar
• Gianni AM, Bregni M, Siena S, Villa S, Sciorelli A, Ravagnani F, . Rapid and complete hemopoietic reconstitution following combined transplantation of autologous blood and bone marrow cells: a changing role for high dose chemo-radiotherapy? Hematol Oncol. 1989;7:139–48.
   PubMed Web of Science ®Google Scholar
• de Boer F, Drager AM, Pinedo HM, Kessler FL, van der Wall E, Jonkhoff AR, . Extensive early apoptosis in frozen-thawed CD34-positive stem cells decreases threshold doses for haematological recovery after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant. 2002;29:249–55.
   PubMed Web of Science ®Google Scholar
• Macey, MG, McCarthy DA, van Agthoven A, Newland AC. How should CD34+ cells be analysed? A study of three classes of antibody and five leucocyte preparation procedures. J Immunol Methods. 1997;204:175–88.
   PubMed Web of Science ®Google Scholar
• Allan DS, Keeney M, Howson-Jan K, Popma J, Weir K, Bhatia M, . Number of viable CD34 (+) cells reinfused predicts engraftment in autologous hematopoietic stem cell transplantation. Bone Marrow Transplant. 2002;29:967–72.
   PubMed Web of Science ®Google Scholar
• Olivero S, Alario T, Ladaique P, Haccoun M, Viens P, Blaise D, . CD34+ cell enumeration in peripheral blood and apheresis samples, using two laboratory diagnostic kits or an institutional protocol. Bone Marrow Transplant. 1999;23:387–94.
   PubMedGoogle Scholar